Managing Collapsed or Seriously Ill Participants of Ultra-Endurance Events in Remote Environments

详细信息    查看全文

• 作者：Martin D. Hoffman (1) (7)
  Ian R. Rogers (2)
  Jeremy Joslin (3)
  Chad A. Asplund (4)
  William O. Roberts (5)
  Benjamin D. Levine (6)
  
  1. Department of Physical Medicine and Rehabilitation ; University of California Davis Medical Center ; Sacramento ; CA ; USA
  7. Department of Physical Medicine and Rehabilitation (117) ; Sacramento VA Medical Center ; 10535 Hospital Way ; Sacramento ; CA ; 95655-1200 ; USA
  2. St. John of God Murdoch Hospital and University of Notre Dame ; Murdoch ; WA ; Australia
  3. Department of Emergency Medicine ; State University of New York Upstate Medical University ; Syracuse ; NY ; USA
  4. Department of Family Medicine ; Georgia Regents University ; Augusta ; GA ; USA
  5. Department of Family Medicine and Community Health ; University of Minnesota ; Minneapolis ; MN ; USA
  6. Institute for Exercise and Environmental Medicine ; Texas Health Presbyterian Dallas ; and Division of Cardiology ; University of Texas Southwestern Medical Center at Dallas ; Dallas ; TX ; USA
  
• 刊名：Sports Medicine
• 出版年：2015
• 出版时间：February 2015
• 年：2015
• 卷：45
• 期：2
• 页码：201-212
• 全文大小：255 KB
• 参考文献：1. Cejka N, R眉st CA, Lepers R, et al. Participation and performance trends in 100-km ultra-marathons worldwide. J Sports Sci. 2014;32:354鈥?6. CrossRef
  2. Hoffman MD, Ong JC, Wang G. Historical analysis of participation in 161聽km ultramarathons in North America. Int J Hist Sport. 2010;27:1877鈥?1. CrossRef
  3. Ultrarunning鈥攖he year in review. Ultrarunning. 2014:30鈥?7.
  4. Bishop GW, Fallon KE. Musculoskeletal injuries in a 6-day track race: ultramarathoner鈥檚 ankle. Clin J Sport Med. 1999;9:216鈥?0. CrossRef
  5. Fallon KE. Musculoskeletal injuries in the ultramarathon: the 1990 Westfield Sydney to Melbourne run. Br J Sports Med. 1996;30:319鈥?3. CrossRef
  6. Graham SM, McKinley M, Chris CC, et al. Injury occurrence and mood states during a desert ultramarathon. Clin J Sports Med. 2012;0:1鈥?.
  7. Hoffman MD, Pasternak A, Rogers IR, et al. Consensus guidelines for medical services at ultra-endurance foot races in remote environments. Sports Med. 2014;44:1055鈥?9. CrossRef
  8. Holtzhausen LM, Noakes TD. Collapsed ultraendurance athlete: proposed mechanisms and an approach to management. Clin J Sport Med. 1997;7:292鈥?01. CrossRef
  9. Khodaee M, Ansari M. Common ultramarathon injuries and illnesses: race day management. Curr Sports Med Rep. 2012;11:290鈥?. CrossRef
  10. Krabak BJ, Waite B, Schiff MA. Study of injury and illness rates in multiday ultramarathon runners. Med Sci Sports Exerc. 2011;43:2314鈥?0. CrossRef
  11. Laird RH. Medical care at ultraendurance triathlons. Med Sci Sports Exerc. 1989;21(5 Suppl):S222鈥?. CrossRef
  12. McGowan V, Hoffman MD. Characterization of medical care at the 161-km Western States Endurance Run. Wildernes Environ Med. 2014. doi:10.1016/j.wem.2014.06.015 [Epub ahead of print].
  13. McLaughlin KA, Townes DA, Wedmore IS, et al. Pattern of injury and illness during expedition-length adventure races. Wilderness Environ Med. 2006;17:158鈥?1. CrossRef
  14. Reid SA, King MJ. Serum biochemistry and morbidity among runners presenting for medical care after an Australian mountain ultramarathon. Clin J Sport Med. 2007;17:307鈥?0. CrossRef
  15. Scheer BV, Murray A. Al Andalus ultra trail: an observation of medical interventions during a 219-km, 5-day ultramarathon stage race. Clin J Sport Med. 2011;21:444鈥?. CrossRef
  16. Schwabe K, Schwellnus M, Derman W, et al. Medical complications and deaths in 21 and 56聽km road race runners: a 4-year prospective study in 65,865 runners鈥擲AFER study I. Br J Sports Med. 2014;48(11):912鈥?. CrossRef
  17. Speedy DB, Rogers IR, Noakes TD, et al. Diagnosis and prevention of hyponatremia at an ultradistance triathlon. Clin J Sport Med. 2000;10:52鈥?. CrossRef
  18. Townes DA, Talbot TS, Wedmore IS, et al. Event medicine: injury and illness during an expedition-length adventure race. J Emerg Med. 2004;27:161鈥?. CrossRef
  19. Asplund CA, O鈥機onnor FG, Noakes TD. Exercise-associated collapse: an evidence-based review and primer for clinicians. Br J Sports Med. 2011;45:1157鈥?2. CrossRef
  20. Brennan FH, O鈥機onnor FG. Emergency triage of collapsed endurance athletes: a stepwise approach to on-site treatment. Phys Sportsmed. 2005;33:28鈥?5. CrossRef
  21. Childress MA, O鈥機onnor FG, Levine BD. Exertional collapse in the runner: evaluation and management in fieldside and office-based settings. Clin Sports Med. 2010;29:459鈥?6. CrossRef
  22. Lento PH, Sullivan WJ. The downed runner. Phys Med Rehabil Clin N Am. 2005;16:831鈥?9. CrossRef
  23. Roberts WO. Exercise-associated collapse care matrix in the marathon. Sports Med. 2007;37:431鈥?. CrossRef
  24. Speedy DB, Noakes TD, Holtzhausen LM. Exercise-associated collapse: postural hypotension, or something deadlier? Phys Sportsmed. 2003;31:23鈥?.
  25. Bennett BL, Hew-Butler T, Hoffman MD, et al. Wilderness Medical Society practice guidelines for treatment of exercise-associated hyponatremia. Wilderness Environ Med. 2013;24:228鈥?0. CrossRef
  26. Burdick TE. Wilderness event medicine: planning for mass gatherings in remote areas. Travel Med Infect Dis. 2005;3:249鈥?8. CrossRef
  27. Paal P, Milani M, Brown D, et al. Termination of cardiopulmonary resuscitation in mountain rescue. High Alt Med Biol. 2012;13:200鈥?. CrossRef
  28. Wright JM, Islas AA. Concussion management in the wilderness. Wilderness Environ Med. 2014;25:319鈥?4.
  29. Dunn L. Raised intracranial pressure. J Neurol Neurosurg Psychiatry. 2002;73(Suppl 1):i23鈥?.
  30. Quinn R, Williams J, Bennett B, et al. Wilderness Medical Society practice guidelines for spine immobilization in the austere environment. Wilderness Environ Med. 2013;24:241鈥?2. CrossRef
  31. Roberts WO. A 12-year profile of medical injury and illness for the Twin Cities Marathon. Med Sci Sports Exerc. 2000;32:1549鈥?5. CrossRef
  32. Roberts WO. Exercise-associated collapse in endurance events: a classification system. Phys Sportsmed. 1989;17:49鈥?5.
  33. Holtzhausen LM, Noakes TD. The prevalence and significance of post-exercise (postural) hypotension in ultramarathon runners. Med Sci Sports Exerc. 1995;27:1595鈥?01. CrossRef
  34. Holtzhausen LM, Noakes TD, Kroning B, et al. Clinical and biochemical characteristics of collapsed ultra-marathon runners. Med Sci Sports Exerc. 1994;26:1095鈥?01. CrossRef
  35. Hastings JL, Levine BD. Syncope in the athletic patient. Prog Cardiovasc Dis. 2001;54:438鈥?4. CrossRef
  36. ISIS-2 Collaborative Group. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. Lancet. 1988;332:349鈥?0. CrossRef
  37. Blomstr枚m-Lundqvist C, Scheinman MM, Aliot EM, et al. ACC/AHA/ESC guidelines for the management of patients with supraventricular arrhythmias鈥攅xecutive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients with Supraventricular Arrhythmias) developed in collaboration with NASPE-Heart Rhythm Society. J Am Coll Cardiol. 2003;42:1493鈥?31. CrossRef
  38. Smith G, Morgans A, Boyle M. Use of the Valsalva manoeuvre in the prehospital setting: a review of the literature. Emerg Med J. 2009;26:8鈥?0. CrossRef
  39. Shapiro SY, Seidman DS. Field and clinical observations of exertional heat stroke patients. Med Sci Sport Exerc. 1990;22:6鈥?4. CrossRef
  40. Vicario SJ, Okabajue R, Haltom T. Rapid cooling in classic heatstroke: effect on mortality rates. Am J Emerg Med. 1986;4:394鈥?. CrossRef
  41. Smith JE. Cooling methods used in the treatment of exertional heat illness. Br J Sports Med. 2005;39:503鈥?. CrossRef
  42. Casa DJ, McDermott BP, Lee EC, et al. Cold water immersion: the gold standard for exertional heatstroke treatment. Exerc Sport Sci Rev. 2007;35:141鈥?. CrossRef
  43. Lipman GS, Eifling KP, Ellis MA, et al. Wilderness Medical Society practice guidelines for the prevention and treatment of heat-related illness. Wilderness Environ Med. 2013;24:351鈥?1. CrossRef
  44. Brown DJA, Brugger H, Boyd J, et al. Accidental hypothermia. N Engl J Med. 2012;367:1930鈥?. CrossRef
  45. Giesbrecht GG. Emergency treatment of hypothermia. Emerg Med (Australas). 2001;13:9鈥?6. CrossRef
  46. Grueskin J, Tanen DA, Harvey P, et al. A pilot study of mechanical stimulation and cardiac dysrhythmias in a porcine model of induced hypothermia. Wilderness Environ Med. 2007;18:133鈥?. CrossRef
  47. Lumb AN, Gallen IW. Diabetes management for intense exercise. Curr Opin Endocrinol Diabetes Obes. 2009;16:150鈥?. CrossRef
  48. Graveling AJ, Frier BM. Risks of marathon running and hypoglycaemia in type 1 diabetes. Diabet Med. 2010;27:585鈥?. CrossRef
  49. Baska RS, Moses FM, Graeber G, et al. Gastrointestinal bleeding during an ultramarathon. Dig Dis Sci. 1990;35:276鈥?. CrossRef
  50. Glace B, Murphy C, McHugh M. Food and fluid intake and disturbances in gastrointestinal and mental function during an ultramarathon. Int J Sport Nutr Exerc Metab. 2002;12:414鈥?7.
  51. Glace BW, Murphy CA, McHugh MP. Food intake and electrolyte status of ultramarathoners competing in extreme heat. J Am Coll Nutr. 2002;21(6):553鈥?. CrossRef
  52. Hoffman MD, Fogard K. Factors related to successful completion of a 161-km ultramarathon. Int J Sports Physiol Perform. 2011;6:25鈥?7.
  53. Stuempfle KJ, Hoffman MD, Hew-Butler T. Association of gastrointestinal distress in ultramarathoners with race diet. Int J Sport Nutr Exerc Metabol. 2013;23:103鈥?.
  54. Attvall S, Lager I, Smith U. Rectal glucose administration cannot be used to treat hypoglycemia. Diabetes Care. 1985;8:412鈥?. CrossRef
  55. Vukmir RB, Paris PM, Yealy DM. Glucagon: prehospital therapy for hypoglycemia. Ann Emerg Med. 1991;20:375鈥?. CrossRef
  56. Hew-Butler T, Ayus JC, Kipps C, et al. Statement of the Second International Exercise-Associated Hyponatremia Consensus Development Conference, New Zealand, 2007. Clin J Sport Med. 2008;18:111鈥?1. CrossRef
  57. Bennett BL, Hew-Butler T, Hoffman MD, et al. In reply to clinical practice guidelines for treatment of exercise-associated hyponatremia. Wilderness Environ Med. 2013;24:468鈥?1. CrossRef
  58. Ayus JC, Varon J, Arieff AI. Hyponatremia, cerebral edema, and noncardiogenic pulmonary edema in marathon runners. Ann Intern Med. 2000;132:711鈥?. CrossRef
  59. Frizzell RT, Lang GH, Lowance DC, et al. Hyponatremia and ultramarathon running. JAMA. 1986;255:772鈥?. CrossRef
  60. Hoffman MD, Stuempfle KJ, Sullivan K, et al. Exericise-associated hyponatremia with exertional rhabdomyolysis: importance of proper treatment. Clin Nephrol. 2014. [Epub ahead of print].
  61. Siegel AJ, d鈥橦emecourt P, Adner MM, et al. Exertional dysnatremia in collapsed marathon runners: a critical role for point-of-care testing to guide appropriate therapy. Am J Clin Path. 2009;132(3):336鈥?0. CrossRef
  62. Elsaesser TF, Pang PS, Malik S, et al. Large-volume hypertonic saline therapy in endurance athlete with exercise-associated hyponatremic encephalopathy. J Emerg Med. 2013;44:1132鈥?. CrossRef
  63. Hoffman MD, Hew-Butler T, Schwellnus M. Regarding the Wilderness Medical Society practice guidelines for heat-related illness. Wilderness Environ Med. 2014;25(2):246鈥?. CrossRef
  64. Hoffman MD, Weiss RH. Symptomatic hypotonic hyponatremia presenting at high altitude. Wilderness Environ Med. 2014. [Epub ahead of print].
  65. Noakes TD. Hyponatremia in distance athletes: pulling the IV on the 鈥榙ehydration myth鈥? Phys Sportsmed. 2000;28:71鈥?. CrossRef
  66. Pyne S. Intravenousfluids post marathon: when and why? Sports Med. 2007;37:434鈥?. CrossRef
  67. Hoffman MD, Hew-Butler T, Stuempfle KJ. Exercise-associated hyponatremia and hydration status in 161-km ultramarathoners. Med Sci Sports Exerc. 2013;45:784鈥?1. CrossRef
  68. Noakes TD, Sharwood K, Speedy D, et al. Three independent biological mechanisms cause exercise-associated hyponatremia: evidence from 2,135 weighed competitive athletic performances. Proc Natl Acad Sci. 2005;102:18550鈥?. CrossRef
  69. McGarvey J, Thompson J, Hanna C, et al. Sensitivity and specificity of clinical signs for assessment of dehydration in endurance athletes. Br J Sports Med. 2010;44:716鈥?. CrossRef
  70. Luks AM, McIntosh SE, Grissom CK, et al. Wilderness Medical Society consensus guidelines for the prevention and treatment of acute altitude illness. Wilderness Environ Med. 2010;21:146鈥?5. CrossRef
  71. Talbot TS, Townes DA, Wedmore IS. To air is human: altitude illness during an expedition length adventure race. Wilderness Environ Med. 2004;15:90鈥?. CrossRef
  72. Eide RP 3rd, Asplund CA. Altitude illness: update on prevention and treatment. Curr Sports Med Rep. 2012;11:124鈥?0. CrossRef
  73. Maggiorini M. High altitude-induced pulmonary oedema. Cardiovasc Res. 2006;72:41鈥?0. CrossRef
  74. Boyd JJ, Agazzi G, Svajda D, et al. Venomous snakebite in mountainous terrain: prevention and management. Wilderness Environ Med. 2007;18:190鈥?02. CrossRef
  75. Lavonas EJ, Ruha AM, Banner W, et al. Unified treatment algorithm for the management of crotaline snakebite in the United States: results of an evidence-informed consensus workshop. BMC Emerg Med. 2011;3(11):2. doi:10.1186/1471-227X-11-2 . CrossRef
  76. Quan D. North American poisonous bites and stings. Crit Care Clin. 2012;28:633鈥?9. CrossRef
  77. Bush SP, Green SM, Laack TA, et al. Pressure immobilization delays mortality and increases intracompartmental pressure after artificial intramuscular rattlesnake envenomation in a porcine model. Ann Emerg Med. 2004;44:599鈥?04. CrossRef
  78. Seifert S, White J, Currie BJ. Pressure bandaging for North American snake bite? No! Clin Toxicol (Phila). 2011;49:883鈥?. CrossRef
  
• 刊物主题：Sports Medicine;
• 出版者：Springer International Publishing
• ISSN：1179-2035

文摘

Increasing participation in ultramarathons and other ultra-endurance events amplifies the potential for serious medical issues during and immediately following these competitions. Since these events are often located in remote settings where access may be extremely limited; the diagnostic capabilities, treatment options, and expectations of medical care may differ from those of urban events. This work outlines a process for assessment and treatment of athletes presenting for medical attention in remote environments, with a focus on potentially serious conditions such as major trauma, acute coronary syndrome, exertional heat stroke, hypothermia, hypoglycemia, exercise-associated hyponatremic encephalopathy, severe dehydration, altitude illness, envenomation, anaphylaxis, and bronchospasm. A list of suggested medical supplies is provided and discussed. But, given that diagnostic and treatment options may be extremely limited in remote settings, it is important for medical providers to understand how to assess and manage the most common serious medical issues with limited resources, and to be prepared to make presumptive diagnoses when necessary.